LHC Group Stock Price, News & Analysis (NASDAQ:LHCG)

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) issued its quarterly earnings results on Wednesday, August, 7th. The health services provider reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.01 by $0.06. The health services provider had revenue of $517.84 million for the quarter, compared to analyst estimates of $524.24 million. LHC Group had a return on equity of 8.83% and a net margin of 4.20%. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.84 EPS. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for LHC Group.

LHC Group will be holding an earnings conference call on Wednesday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

LHC Group issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $4.25 to $4.35 for the period, compared to the Thomson Reuters consensus estimate of $4.31. The company issued revenue guidance of $2.09-2.14 billion, compared to the consensus revenue estimate of $2.11 billion.

11 Wall Street analysts have issued 1 year price targets for LHC Group's stock. Their forecasts range from $114.00 to $146.00. On average, they anticipate LHC Group's share price to reach $130.80 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price. View Analyst Price Targets for LHC Group.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

Media headlines about LHCG stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. LHC Group earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned press coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for LHC Group.

LHC Group saw a drop in short interest in September. As of September 30th, there was short interest totalling 1,860,000 shares, a drop of 7.0% from the August 30th total of 2,000,000 shares. Based on an average daily volume of 220,100 shares, the short-interest ratio is presently 8.5 days. Approximately 6.3% of the shares of the company are sold short. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), The Providence Service (PRSC), Tivity Health (TVTY), BioScrip (BIOS), Cross Country Healthcare (CCRN), Interpace Diagnostics Group (IDXG) and Bio-Reference Laboratories (BRLI).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Home Depot (HD), Visa (V), Cisco Systems (CSCO), Chevron (CVX), Verizon Communications (VZ), Johnson & Johnson (JNJ), Okta (OKTA), Alibaba Group (BABA), CVS Health (CVS) and Exxon Mobil (XOM).

LHC Group's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Tributary Capital Management LLC (0.88%), Summit Creek Advisors LLC (0.51%), Copper Rock Capital Partners LLC (0.48%), Scout Investments Inc. (0.29%), Rhumbline Advisers (0.28%) and Calamos Advisors LLC (0.15%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, Calamos Advisors LLC, Scout Investments Inc., Envestnet Asset Management Inc. and Brinker Capital Inc.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Insider Buying and Selling for LHC Group.

LHCG stock was purchased by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, State of Alaska Department of Revenue, Strs Ohio, Summit Creek Advisors LLC, Bridge City Capital LLC, Tuttle Tactical Management, Moors & Cabot Inc. and Rhumbline Advisers. View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $113.39.

LHC Group has a market capitalization of $3.57 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]